Prevounce Health offers a cloud-based remote care management platform, proprietary cellularly connected patient devices, and expert managed services for remote patient monitoring (RPM), chronic care management (CCM), and wellness programs. Launched in 2019 by physicians, practice managers, and healthcare attorneys and led by founder and CEO Daniel Tashnek, the company tailors solutions for practices, health systems, and payors. Its software is device-agnostic and acts as a data aggregator, connecting to hundreds of third-party platforms and devices via integrations and APIs. Prevounce provides full-service device shipping and logistics and combines software, custom devices, care services, and logistics to meet client business and patient outcome goals. More than 450 healthcare organizations use Prevounce’s products to manage over 26,000 patients across conditions including hypertension, heart failure, diabetes, COPD, and preeclampsia. The company plans to use the new funding to accelerate product development and scale its team.

Total raised

$3M

Funding rounds

1

Latest round

Series A

Latest activity

Oct 2023